Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Oct 14;27(9):2262-2264.
doi: 10.1093/neuonc/noaf137.

Unraveling the effects of radiotherapy on the blood-brain barrier: Fact or fiction?

Affiliations
Editorial

Unraveling the effects of radiotherapy on the blood-brain barrier: Fact or fiction?

Rupesh Kotecha et al. Neuro Oncol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

R.K.: Honoraria from Accuray Inc., Elekta AB, ViewRay Inc., Novocure Inc., Elsevier Inc., Brainlab, Kazia Therapeutics, Castle Biosciences, and Ion Beam Applications and institutional research funding from Medtronic Inc., Blue Earth Diagnostics Ltd., Novocure Inc., GT Medical Technologies, AstraZeneca, Exelixis, ViewRay Inc., Brainlab, Cantex Pharmaceuticals, Kazia Therapeutics, and Ion Beam Applications. M.P.M.: Honoraria from AIQ, Chimerix, Kazia, Mevion, Telix; stock in Chimerix.

Comment on

References

    1. Pardridge WM. The blood-brain barrier: Bottleneck in brain drug development. NeuroRx. 2005;2(1):3–14. - PMC - PubMed
    1. Zhang W, Grams MP, Oberoi RK, et al. The impact of therapeutic radiation on drug distribution across the blood-brain barrier in normal mouse brain and orthotopic GBM tumors [published online ahead of print March 31, 2025]. Neuro Oncol. 2025;27(9):2250–2261. - PMC - PubMed
    1. Hart E, Ode Z, Derieppe MPP, et al. Blood-brain barrier permeability following conventional photon radiotherapy - A systematic review and meta-analysis of clinical and preclinical studies. Clin Transl Radiat Oncol. 2022;35:44–55. - PMC - PubMed
    1. Fang L, Sun X, Song Y, et al. Whole-brain radiation fails to boost intracerebral gefitinib concentration in patients with brain metastatic non-small cell lung cancer: A self-controlled, pilot study. Cancer Chemother Pharmacol. 2015;76(4):873–877. - PubMed
    1. Zeng YD, Liao H, Qin T, et al. Blood-brain barrier permeability of gefitinib in patients with brain metastases from non-small-cell lung cancer before and during whole brain radiation therapy. Oncotarget. 2015;6(10):8366–8376. - PMC - PubMed

LinkOut - more resources